单心室姑息治疗中共同房室瓣衰竭的长期风险
基于双国家人群登记数据,回顾性分析136例单心室合并共同房室瓣患者,其中114例有完整超声随访。中位随访10.2年,28年共同房室瓣衰竭累积发生率为62%(95%CI 49-74%),瓣膜修复后4年免于修复失败率仅50%(95%CI 34-75%)。结论认为此类患者瓣膜功能持续下降,多数在30岁内发生瓣膜衰竭。
要点
- 单心室合并共同房室瓣患者28年瓣膜衰竭累积发生率达62%。
- 瓣膜修复后4年免于修复失败率仅50%,再干预风险高。
- 多数患者在30岁内经历瓣膜衰竭,需长期密切监测。
核心结论
- 单心室合并共同房室瓣患者瓣膜功能持续下降,多数在30岁内发生瓣膜衰竭。
研究设计与样本
- 回顾性队列研究,数据来自双国家人群登记,从1468例Fontan幸存者中识别136例共同房室瓣患者,114例有完整超声随访。
主要发现
- 28例接受瓣膜手术(24例初次修复,4例置换);修复后4年免于修复失败率50%(95%CI 34-75%)。
- 另有30例出现中度及以上反流,其中6例NYHA≥3级,10例Fontan失败,0例死亡。
- 28年共同房室瓣衰竭复合终点累积发生率为62%(95%CI 49-74%)。
临床怎么用
- 对单心室合并共同房室瓣患者应长期监测瓣膜功能,警惕30岁内瓣膜衰竭。
- 瓣膜修复后需密切随访,因修复失败及再干预风险较高。
局限性
- 回顾性研究,部分患者(114/136)有完整超声随访,可能存在信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the risk of atrioventricular valve failure (valve intervention or moderate or greater regurgitation) during the lifetime of patients with single ventricle physiology and common atrioventricular valve. METHODS: Patients' data were extracted from an existing bi-national, population based registry. A retrospective review of their medical records was undertaken to determine the incidence of atrioventricular valve repair/replacement or moderate or greater regurgitation. RESULTS: From a registry of 1468 Fontan survivors, 136 patients with common atrioventricular valve were identified. Complete echocardiographic follow-up was available for 114 patients. Median length of follow-up was 10.2 years (interquartile range 5-15 years). Twenty-five year survival and freedom from Fontan failure were 94% [95% confidence interval (CI), 88-100%] and 74% (95% CI, 64-87%), respectively. Twenty-eight patients underwent 24 initial repairs and 4 replacements. The 24 patients undergoing repair subsequently needed 6 re-repairs, 2 replacements and 8 had moderate or greater regurgitation at last follow-up. Four-year freedom from atrioventricular valve repair failure was 50% (95% CI, 34-75%). An additional 30 patients developed moderate or greater atrioventricular valve regurgitation (6 New York Heart Association ≥3, 10 Fontan failures, 0 deaths). Cumulative incidence of the composite endpoint of atrioventricular valve failure at 28 years was 62% (95% CI, 49-74%). CONCLUSIONS: Patients with single ventricle physiology and common atrioventricular valve experience a continuous decline in valve function. The majority of patients experience valve failure in the first 30 years of life.
引用
- King G, Gentles TL, Winlaw DS, et al. Common atrioventricular valve failure during single ventricle palliation†. Eur J Cardiothorac Surg. 2017. PMID: 28369323. doi:10.1093/ejcts/ezx025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。